Literature DB >> 33924287

A Case of Thrombotic Thrombocytopenic Purpura without Pathognomonic Schistocytes.

Kevin Yu1, Min Yan2,3.   

Abstract

Patients diagnosed with thrombotic thrombocytopenic purpura (TTP) typically present with microangiopathic hemolytic anemia (MAHA) and thrombocytopenia; these two clinical manifestations were often believed to be essential indicators of TTP. However, such indicators are not always present in every case. Here, we present a patient affected by TTP but showing no distinctive schistocytes on blood smear review. TTP was diagnosed through a critically low level of a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13 (ADAMTS13) activity. Awareness of such an atypical presentation of TTP is essential for timely treatment to prevent serious and even fatal outcomes for patients.

Entities:  

Keywords:  blood smear; schistocytes; thrombotic thrombocytopenic purpura

Year:  2021        PMID: 33924287     DOI: 10.3390/clinpract11020033

Source DB:  PubMed          Journal:  Clin Pract        ISSN: 2039-7275


  10 in total

1.  Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.

Authors:  Yosef Kalish; Amihai Rottenstreich; Deborah Rund; Sarit Hochberg-Klein
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 2.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2017-08-02       Impact factor: 22.113

3.  A case series of atypical presentations of thrombotic thrombocytopenic purpura.

Authors:  Iman Imanirad; Anita Rajasekhar; Marc Zumberg
Journal:  J Clin Apher       Date:  2012-03-29       Impact factor: 2.821

4.  Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai; Keith Shulman
Journal:  Eur J Haematol       Date:  2003-03       Impact factor: 2.997

5.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

Review 6.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

7.  Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident.

Authors:  Katharine A Downes; Roslyn Yomtovian; H M Tsai; Bernard Silver; Cynthia Rutherford; Ravindra Sarode
Journal:  J Clin Apher       Date:  2004       Impact factor: 2.821

8.  Atypical presentations of thrombotic thrombocytopenic purpura.

Authors:  Timothy E O'Brien; Edward D Crum
Journal:  Int J Hematol       Date:  2002-12       Impact factor: 2.490

9.  Atypical Thrombotic Thrombocytopenic Purpura Presenting as Stroke.

Authors:  Pradeepthi Badugu; Modupe Idowu
Journal:  Case Rep Hematol       Date:  2019-01-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.